Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D - PubMed (original) (raw)
Meta-Analysis
Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D
Cedric F Garland et al. Am J Public Health. 2014 Aug.
Abstract
We examined the relationship between serum 25-hydroxyvitamin D (25[OH]D) and all-cause mortality. We searched biomedical databases for articles that assessed 2 or more categories of 25(OH)D from January 1, 1966, to January 15, 2013. We identified 32 studies and pooled the data. The hazard ratio for all-cause mortality comparing the lowest (0-9 nanograms per milliliter [ng/mL]) to the highest (> 30 ng/mL) category of 25(OH)D was 1.9 (95% confidence interval = 1.6, 2.2; P < .001). Serum 25(OH)D concentrations less than or equal to 30 ng/mL were associated with higher all-cause mortality than concentrations greater than 30 ng/mL (P < .01). Our findings agree with a National Academy of Sciences report, except the cutoff point for all-cause mortality reduction in this analysis was greater than 30 ng/mL rather than greater than 20 ng/mL.
Figures
FIGURE 1—
Results of literature search for studies of serum 25-hydroxyvitamin D in association with all-cause mortality. Note. 25(OH)D = 25-hydroxyvitamin D.
FIGURE 2—
Age-adjusted all-cause mortality hazard ratios comparing lowest with highest categories of serum 25-hydroxyvitamin D, with 95% confidence intervals, in 32 studies of serum 25-hydroxyvitamin D in association with all-cause mortality, 1966–2013. Note. CI = confidence interval
FIGURE 3—
Overall age-adjusted hazard ratios for mortality, in 32 studies of serum 25-hydroxyvitamin D in association with all-cause mortality combined: 1966–2013. Note. 25(OH)D = 25-hydroxyvitamin D.
FIGURE 4—
Dose–response relationships in each study between serum 25-hydroxyvitamin D and age-adjusted hazard ratios for all-cause mortality, in 32 studies of serum 25-hydroxyvitamin D in association with all-cause mortality: 1966–2013 Note. 25(OH)D = 25-hydroxyvitamin D. 1. Thomas et al.; 2. Semba et al. 2010; 3. Zittermann et al.; 4. Jia et al.; 5. Semba et al. 2009; 6. Dobnig et al.; 7. Anderson et al.; 8. Ginde et al.; 9. Virtanen et al.; 10. Von Muhlen et al. (men); 11. Von Muhlen et al. (women); 12. Zhao et al.; 13. Saliba et al.; 14. Schöttker et al.; 15. Johansson et al.; 16. Signorello et al.; 17. Ford et al.; 18. Szulc et al.; 19. Pilz et al. (2009); 20. Visser et al.; 21. Skaaby et al.; 22. Kuroda et al.; 23. Melamed et al.; 24. Pilz et al. (2012); 25. La Croix et al.; 26. Kramer et al.; 27. Kestenbaum et al.; 28. Hutchinson et al.; 29. Michaëlsson et al.; 30. Eaton et al.; 31. Cawthon et al.; 32. Durup et al.; 33. Lin et al.
Similar articles
- Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults.
Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM, Ferrucci L. Semba RD, et al. Eur J Clin Nutr. 2010 Feb;64(2):203-9. doi: 10.1038/ejcn.2009.140. Epub 2009 Dec 2. Eur J Clin Nutr. 2010. PMID: 19953106 Free PMC article. - Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women.
Semba RD, Houston DK, Ferrucci L, Cappola AR, Sun K, Guralnik JM, Fried LP. Semba RD, et al. Nutr Res. 2009 Aug;29(8):525-30. doi: 10.1016/j.nutres.2009.07.007. Nutr Res. 2009. PMID: 19761886 Free PMC article. - Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies.
Schöttker B, Ball D, Gellert C, Brenner H. Schöttker B, et al. Ageing Res Rev. 2013 Mar;12(2):708-18. doi: 10.1016/j.arr.2012.02.004. Epub 2012 Feb 17. Ageing Res Rev. 2013. PMID: 22343489 Review. - The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA, Zimmermann MB, Rohrmann S. Schmutz EA, et al. Eur J Nutr. 2016 Feb;55(1):393-402. doi: 10.1007/s00394-015-0860-y. Epub 2015 Feb 21. Eur J Nutr. 2016. PMID: 25701092 - Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H, Walter V, Jansen L, Boakye D, Schöttker B, Hoffmeister M, Brenner H. Maalmi H, et al. Nutrients. 2018 Jul 13;10(7):896. doi: 10.3390/nu10070896. Nutrients. 2018. PMID: 30011816 Free PMC article. Review.
Cited by
- The Power of Vitamin D: Is the Future in Precision Nutrition through Personalized Supplementation Plans?
Mavar M, Sorić T, Bagarić E, Sarić A, Matek Sarić M. Mavar M, et al. Nutrients. 2024 Apr 15;16(8):1176. doi: 10.3390/nu16081176. Nutrients. 2024. PMID: 38674867 Free PMC article. Review. - The evident and the hidden factors of vitamin D status in older people during COVID-19 pandemic.
Schmidt Azevedo P, Fock RA, Pereira FL, Dos Santos PP, Ferro FC, Sacco N, Polegato BF, Zornoff LM, Okoshi MP, Achterberg W, de Paiva SR. Schmidt Azevedo P, et al. Nutrire. 2021;46(1):1. doi: 10.1186/s41110-020-00131-3. Epub 2021 Jan 6. Nutrire. 2021. PMID: 38624693 Free PMC article. Review. - Severe Vitamin D Deficiency-A Possible Cause of Resistance to Treatment in Psychiatric Pathology.
Ciobanu AM, Petrescu C, Anghele C, Manea MC, Ciobanu CA, Petrescu DM, Antonia MO, Riga S. Ciobanu AM, et al. Medicina (Kaunas). 2023 Nov 21;59(12):2056. doi: 10.3390/medicina59122056. Medicina (Kaunas). 2023. PMID: 38138159 Free PMC article. Review. - Infections and Autoimmunity-The Immune System and Vitamin D: A Systematic Review.
Wimalawansa SJ. Wimalawansa SJ. Nutrients. 2023 Sep 2;15(17):3842. doi: 10.3390/nu15173842. Nutrients. 2023. PMID: 37686873 Free PMC article. Review. - Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate.
EFSA Panel on Nutrition, Novel Foods and FoodAllergens (NDA); Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Lanham-New S, Passeri G, Craciun I, Fabiani L, De Sousa RF, Martino L, Martínez SV, Naska A. EFSA Panel on Nutrition, Novel Foods and FoodAllergens (NDA), et al. EFSA J. 2023 Aug 8;21(8):e08145. doi: 10.2903/j.efsa.2023.8145. eCollection 2023 Aug. EFSA J. 2023. PMID: 37560437 Free PMC article.
References
- Lowe LC, Guy M, Mansi J et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164–1169. - PubMed
- Bertone-Johnson ER, Chen W, Holick MF et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991–1997. - PubMed
- Abbas S, Linseisen J, Slanger T et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case–control study. Carcinogenesis. 2008;29(1):93–99. - PubMed
- Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2(8673):1176–1178. - PubMed
- Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985;1(8424):307–309. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical